Avidity Biosciences (RNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...

As previously reported, Wedbush initiated coverage of Wave Life Sciences (WVE) with an Outperform rating and $18 price target Wave stands out ...

Genomic Testing Cooperative (GTC) today announced it received UKCA marks for its Hematology Profile Plus, Solid Tumor Plus as ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Tantalizing clues in 4-billion-year-old asteroid Bennu samples could reveal particular molecular formations that some ...

AIR-001 is designed to restore functional alpha-1 antitrypsin (M-AAT) protein production by precisely repairing the SERPINA1 mutation (PiZ) to address the underlying cause of both lung and liver ...

The following is a summary of “Trans-omics landscape of systemic vasculitis identified matrix metalloproteinase 12 as a novel ...

Financing led by Venrock Healthcare Capital Partners with co-lead Forbion Growth, and participation from RTW Investments, Nextech Invest, and other new ...

A study in Ontario found no traces of influenza A viral ribonucleic acid (RNA) in 117 samples of pasteurized retail milk collected in April and May 2024, ...

Six (40%) of 15 toys in the sick waiting room were positive for picornaviral RNA before cleaning; after cleaning, 4 (27%) of 15 were positive in spite of the fact that RNA was removed from 4 of 6 ...

MoonLake Immunotherapeutics has secured up to $500 million in non-dilutive financing from Hercules Capital, bolstering its ...

In this week’s edition of InnovationRx, we look at Trump's massive health agency layoffs, Palantir’s trade secret lawsuit, Gather Health’s new primary care model, Airna’s $155 million deal, and more.